Completion Demonstrates the Company's Strong Commitment to Continuous Process Improvement
FREMONT, Calif., April 22, 2016 /PRNewswire/ — ValGenesis Inc., the market leader in Enterprise Validation Lifecycle Management Solutions (VLMS) today announced that it had successfully completed the ISO 9001:2008 surveillance audit focused on the development, implementation and maintenance of its software and services.
Logo – http://photos.prnewswire.com/prnh/20160421/358544LOGO
Certification to ISO 9001 requires an accredited third party auditing organization to thoroughly review the company's internal quality management system processes. Third party auditing ensures that the company is capable of consistently delivering products and services that meet customers' requirements and expectations. The completion of the ISO 9001:2008 Surveillance Audit clearly demonstrates that ValGenesis is vigilant in its commitment to the highest quality and standards.
Since 2012, the ValGenesis organization has successfully continued its ISO 9001:2008 certification. In support of its efforts, ValGenesis has leveraged its own validation lifecycle management system platform to dynamically manage its corporate quality management system. ValGenesis Lifecycle Management Solutions (VLMS) has been adopted to manage and automate the software development lifecycle as well as the validation lifecycle and quality management processes.
"Since 2012, the maintenance of ISO 9001:2008 certification has demonstrated ValGenesis's commitment and structured approach to the development, implementation and maintenance of its software and services," said Siva Samy, ValGenesis's Chief Product Strategist. "As a global leader in the validation lifecycle management space, it is imperative that ValGenesis works diligently to improve the internal processes so as to provide the highest quality products and services to its customers. By achieving the ISO 9001:2008 standards certification, ValGenesis ensures that ongoing measurements and improvements are part of its process, allowing the company to maintain its commitment to the highest level of customer satisfaction, while also protecting its customers' investment."
About ValGenesis
ValGenesis, Inc. is the creator of an innovative software platform serving as the foundation for managing compliance-based validation activities in Life Sciences companies. ValGenesis, Inc. provides the first enterprise application to manage the corporate validation lifecycle process. As the only system for managing validation execution and approval 100% electronically, ValGenesis was selected by an industry peer review committee to receive the Parenteral Drug Association (PDA) New Innovative Technology Award. The solution is fully compliant with U.S. FDA 21 CFR Part 11 and Annex 11 requirements. For more information, visit www.valgenesis.com.
Media Contact:
Nancy DeFilippis
Email
510-445-0505 x1025